These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 5875219)

  • 1. Changes in the status of proprietary drugs under federal law.
    Larrick GP
    Pharmakotherapia; 1965; 2(2):119-23. PubMed ID: 5875219
    [No Abstract]   [Full Text] [Related]  

  • 2. Ethnicity is issue in new law affecting research with children as subjects.
    Maloney DM
    Hum Res Rep; 2002 Apr; 17(4):9. PubMed ID: 12374183
    [No Abstract]   [Full Text] [Related]  

  • 3. Progress under the Kefauver-Harris Drug Amendments.
    Rankin WB
    Pharmakotherapia; 1964; 2(1):215-22. PubMed ID: 5875717
    [No Abstract]   [Full Text] [Related]  

  • 4. One decade of food and drug law scholarship: a selected bibliography.
    Noah L
    Food Drug Law J; 2000; 55(4):641-58. PubMed ID: 12025854
    [No Abstract]   [Full Text] [Related]  

  • 5. The legal status of the morning-after pill: abortion or birth control?
    Saylor S
    Univ San Francisco Law Rev; 1991; 25(2):401-27. PubMed ID: 11659519
    [No Abstract]   [Full Text] [Related]  

  • 6. Confronting a new obstacle to reproductive choice: encouraging the development of RU-486 through reform of products liability law.
    Rubin LA
    Rev Law Soc Change; 1990-1991; 18(1):131-59. PubMed ID: 11656168
    [No Abstract]   [Full Text] [Related]  

  • 7. The history and contemporary challenges of the US Food and Drug Administration.
    Borchers AT; Hagie F; Keen CL; Gershwin ME
    Clin Ther; 2007 Jan; 29(1):1-16. PubMed ID: 17379043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RU 486 and the politics of drug regulation in the United States and France.
    Kramnick RK
    Cornell Int Law J; 1992; 25():667-718. PubMed ID: 11656340
    [No Abstract]   [Full Text] [Related]  

  • 9. Prescription drug advertising--should states regulate what is false and misleading?
    Shaeffer J
    Food Drug Law J; 2003; 58(4):629-48. PubMed ID: 15027454
    [No Abstract]   [Full Text] [Related]  

  • 10. Legal issues concerning the promotion of pharmaceutical products on the internet to consumers.
    Reichertz PS
    Food Drug Law J; 1996; 51(3):355-65. PubMed ID: 11797712
    [No Abstract]   [Full Text] [Related]  

  • 11. Food, drugs, and droods: a historical consideration of definitions and categories in American food and drug law.
    Grossman LA
    Cornell Law Rev; 2008 Jul; 93(5):1091-148. PubMed ID: 18618972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enforcement policy: recalls (including product corrections)--guidelines on policy, procedures, and industry responsibilities.
    Fed Regist; 1978 Jun; 43(117):26201-21. PubMed ID: 10316619
    [No Abstract]   [Full Text] [Related]  

  • 13. AIDS and drug pricing: in search of a policy.
    Salbu SR
    Wash Univ Law Q; 1993; 71(3):691-734. PubMed ID: 11652750
    [No Abstract]   [Full Text] [Related]  

  • 14. The dermatologist, the cosmetic chemist, and the new law.
    Brauer EW
    J Med Soc N J; 1965 Oct; 62(10):489-91. PubMed ID: 5213164
    [No Abstract]   [Full Text] [Related]  

  • 15. The use of Food and Drug Administration--approved medications for unlabeled (off-label) uses. The legal and ethical implications.
    Torres A
    Arch Dermatol; 1994 Jan; 130(1):32-6. PubMed ID: 8285737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Food and Drug Administration--part II: Federal agency close-up.
    Kauffman NM; Malevich S; Smith DJ; Petersen-Kauffman LC
    Am J Med Technol; 1980 Jul; 46(7):527-37. PubMed ID: 7405954
    [No Abstract]   [Full Text] [Related]  

  • 17. Antibiotics standards versus standards for other drugs.
    Wright WW
    Am J Hosp Pharm; 1982 Jun; 39(6):1046-7. PubMed ID: 7102691
    [No Abstract]   [Full Text] [Related]  

  • 18. Using drugs in food animals.
    Larkin T
    FDA Consum; 1977 Apr; 11(3):6-9. PubMed ID: 10316530
    [No Abstract]   [Full Text] [Related]  

  • 19. The Food and Drug Administration and patent law at a crossroads: the listing of polymorph patents as a barrier to generic drug entry.
    Srivastava D
    Food Drug Law J; 2004; 59(2):339-54. PubMed ID: 15298015
    [No Abstract]   [Full Text] [Related]  

  • 20. New drugs and the Kefauver-Harris amendment.
    Krantz JC
    J New Drugs; 1966; 6(2):77-9. PubMed ID: 5917906
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.